5 Firms Vie For Lead In Latest Teva Investor Suit

Law360 (August 26, 2019, 6:21 PM EDT) -- Five law firms, including Levi & Korsinsky and Hagens Berman, vied to take the lead Friday in the latest proposed investor class action in Pennsylvania federal court against Teva Pharmaceutical Industries Ltd. over stock losses amid accusations Teva was at the center of a generic-drug price-fixing scheme.

With Friday as the deadline to seek appointment as lead plaintiff and class counsel in the proposed class action filed in June by the Employees’ Retirement System of St. Petersburg, Hagens Berman Sobol Shapiro LLP, Levi & Korsinsky LLP, Saxena White PA, The Rosen Law Firm PA and Bronstein Gewirtz & Grossman LLC all...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS